0QYQ

Gilead Sciences Inc.

Stock London Stock Exchange – Stock Market Prices, News & Analysis

Gilead Sciences Inc. est une entreprise biopharmaceutique américaine, focalisée sur la recherche et le développement de traitements innovants pour des maladies infectieuses, cancéreuses et inflammatoires.

£ 1.44
2.83 %

Gilead Sciences Inc.

£ 1.44
2.83 %
0QYQ

Gilead Sciences Inc. est une entreprise biopharmaceutique américaine, focalisée sur la recherche et le développement de traitements innovants pour des maladies infectieuses, cancéreuses et inflammatoires.

Price history of Gilead Sciences Inc.
Price history of Gilead Sciences Inc.

Performance & Momentum

6 Months 25.74 %
1 Year 28.48 %
3 Years 97.76 %
5 Years 181.19 %

Strategic Analysis

Gilead Sciences Inc. • 2026

Gilead Sciences is positioned as a major player in U.S. biopharma, specializing in the development of innovative treatments targeting infectious diseases, cancer, and inflammation. Its business model is based on strong R&D capabilities and a strategic focus on therapeutic niches with significant unmet medical needs.

Strengths
  • Recognized expertise in infectious diseases with proven treatments
  • Dynamic pipeline incorporating innovations in oncology and immunology
  • Strong track record of growth and adaptation to shifts in the pharmaceutical sector
Weaknesses
  • High dependence on certain key revenue-generating products
  • Regulatory pressures and intense competition in the biotechnology space
Momentum

Gilead's momentum shows a sustained positive trend, reflecting market confidence in the strength of its portfolio and its ongoing innovation. This favorable dynamic suggests an attractive opportunity for long-term investors, while still remaining mindful of regulatory risks.

Similar stocks to Gilead Sciences Inc.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone